Stocks · Health care · Biological Products, (No Diagnostic Substances)

Aura Biosciences, Inc.

AURA Clue Score20
United States Fiscal year ends December CIK 0001501796 Results filed 11 Aug 2026

What the insiders did Net selling

By person

16 insiders · 11 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Matrix Capital Management Company, LP entity
10% owner
—
$39.04M (1)
−$39.04M
0
$0.00
−100.0%
los Pinos Elisabet de
See Remarks
—
$323.37K (2)
−$323.37K
575,815
$3.70M
+77.6%
Janet Jill Hopkins
Chief Medical Officer
—
$195.96K (2)
−$195.96K
380,190
$2.44M
+132.5%
Conor Kilroy
See Remarks
—
$143.40K (2)
−$143.40K
232,693
$1.49M
+142.4%
Anthony S Gibney
See Remarks
—
$82.33K (1)
−$82.33K
265,354
$1.70M
+3,040%
Mark Plavsic
Chief Technology Officer
—
$80.24K (1)
−$80.24K
243,736
$1.56M
+101.2%
Amy Elazzouzi
SVP, Finance & PAO
—
$50.94K (2)
−$50.94K
143,600
$921.91K
+264.1%
Natalie C. Holles
See Remarks
—
—
—
1,153,962
$7.41M
—
David Michael Johnson
Director
—
—
—
194,167
$1.25M
+32.8%
Susan Abu-Absi
Chief Operating Officer
—
—
—
134,513
$863.57K
—
Julie Person
Chief People Officer
—
—
—
107,611
$690.86K
—
Erica Kratz
Chief Reg. & Quality Officer
—
—
—
100,885
$647.68K
—
Sapna Srivastava
Director
—
—
—
38,500
$247.17K
+266.7%
Antony C. Mattessich
Director
—
—
—
38,500
$247.17K
+266.7%
Teresa Marie Bitetti
Director
—
—
—
36,000
$231.12K
—
Jeremy Bender
Director
—
—
—
30,000
$192.60K
—

No percentages here. This company's share count has moved by a factor of 2.1 over the window, from 50,225,312 to 103,704,809 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.